Cargando…

Falling through the Cracks—The Impact of Care Gaps on Lung Function Loss in Cystic Fibrosis

Detalles Bibliográficos
Autores principales:	Love, Allison J., Quon, Bradley S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2023
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502880/ https://www.ncbi.nlm.nih.gov/pubmed/37655958 http://dx.doi.org/10.1513/AnnalsATS.202305-459ED

Ejemplares similares

Nontuberculous Mycobacteria in Cystic Fibrosis
por: Skolnik, Kate, et al.
Publicado: (2016)

TeleHealth or TeleWealth? Equity challenges for the future of cystic fibrosis care (Commentary)()
por: Franciosi, Alessandro N, et al.
Publicado: (2021)

Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)

Optic Disc Swelling and Vision Loss in a Patient with Cystic Fibrosis and Diabetes
por: Iosfina, Ioulia, et al.
Publicado: (2013)

The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
por: Sergeev, Valentine, et al.
Publicado: (2020)

Mitigating the Impact of Socioeconomic Status on Listing for Lung Transplantation in Cystic Fibrosis
por: Hadjiliadis, Denis
Publicado: (2020)

Evaluating Adult Cystic Fibrosis Care in BC: Disparities in Access to a Multidisciplinary Treatment Centre
por: Roberts, James M., et al.
Publicado: (2016)

Sex disparities in cystic fibrosis: review on the effect of female sex hormones on lung pathophysiology and outcomes
por: Lam, Grace Y., et al.
Publicado: (2021)

The Impact of COVID-19 in Cystic Fibrosis
por: Flume, Patrick A., et al.
Publicado: (2022)

Age at Lung Transplant Impacts Post-Transplant Survival in Cystic Fibrosis; Why?
por: Clausen, Emily S., et al.
Publicado: (2021)

Getting Near to “Closing the Gap” in the Pediatric Age Group for the First Personalized Treatment of Cystic Fibrosis
por: van Koningsbruggen-Rietschel, Silke
Publicado: (2021)

Applied public health research - falling through the cracks?
por: Simmons, Rebecca K, et al.
Publicado: (2009)

Falling Through the Cracks: The Current Gap in the Health Care Transition of Patients With Kawasaki Disease: A Scientific Statement From the American Heart Association
por: Dahdah, Nagib, et al.
Publicado: (2021)

Cystic fibrosis revisited
por: Kulkarni, H, et al.
Publicado: (2019)

Patient knowledge and pulmonary medication adherence in adult patients with cystic fibrosis
por: Lin, Ann Hsu-An, et al.
Publicado: (2017)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Experience to date with CFTR modulators during pregnancy and breastfeeding in the British Columbia Cystic Fibrosis clinic
por: Goodwin, Jodi, et al.
Publicado: (2022)

Real-World Safety of CFTR Modulators in the Treatment of Cystic Fibrosis: A Systematic Review
por: Dagenais, Renée V. E., et al.
Publicado: (2020)

Nebulized levofloxacin for chronic Burkholderia cenocepacia pulmonary infection in cystic fibrosis: A case report
por: Dagenais, Renée VE., et al.
Publicado: (2022)

Falling through the cracks: Modeling the formation of social category boundaries
por: Yang, Vicky Chuqiao, et al.
Publicado: (2021)

Cystic Fibrosis Lung Disease and Immunometabolism. Targeting the NLRP3 Inflammasome
por: Cantin, André M.
Publicado: (2019)

CFTR Modulators to the Rescue of Individuals with Cystic Fibrosis and Advanced Lung Disease
por: Myerburg, Mike, et al.
Publicado: (2021)

Metabolomic Biomarkers to Predict and Diagnose Cystic Fibrosis Pulmonary Exacerbations: A Systematic Review
por: Nguyen, Anna-Lisa V., et al.
Publicado: (2022)

Clinical Advances in Cystic Fibrosis
por: Imperlini, Esther, et al.
Publicado: (2022)

Cystic Fibrosis: “Ionocyte Modulators”?
por: Shah, Viral S., et al.
Publicado: (2023)

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
por: Maetz, Jessica, et al.
Publicado: (2021)

Immunomodulatory function of the cystic fibrosis modifier gene BPIFA1
por: Saferali, Aabida, et al.
Publicado: (2020)

A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants
por: Wainwright, Claire E.
Publicado: (2022)

Global burden of nontuberculous mycobacteria in the cystic fibrosis population: a systematic review and meta-analysis
por: Prieto, Miguel D., et al.
Publicado: (2023)

Factors associated with frequent high-cost individuals with cystic fibrosis and their healthcare utilization and cost patterns
por: Desai, Sameer, et al.
Publicado: (2023)

Falling through the cracks of vasculitis classification—a report of three patients
por: Meyrier, A., et al.
Publicado: (2011)

A Systematic Review of the Clinical Efficacy and Safety of CFTR Modulators in Cystic Fibrosis
por: Habib, Al-Rahim R., et al.
Publicado: (2019)

Cystic Fibrosis Respiratory Microbiology Monitoring during a Global Pandemic: Lessons Learned from a Shift to Telehealth
por: Franciosi, Alessandro N., et al.
Publicado: (2022)

Cystic fibrosis in Brazil: achievements in survival
por: Vendrusculo, Fernanda Maria, et al.
Publicado: (2021)

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing
por: Hoppe, Jordana E., et al.
Publicado: (2022)

Call for Changes in Lung Allocation to Reduce Transplant Wait-List Mortality for Cystic Fibrosis
por: Nolley, Eric P., et al.
Publicado: (2019)

How Should the Effects of CFTR Modulator Therapy on Cystic Fibrosis Lung Disease Be Monitored?
por: Ben-Meir, Elad, et al.
Publicado: (2022)

Plasma sCD14 as a Biomarker to Predict Pulmonary Exacerbations in Cystic Fibrosis
por: Quon, Bradley S., et al.
Publicado: (2014)

Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nij63lhbqel9p5dp62fcn8p4jf